#26: NewsBot: AVNR News Avanir Pharmaceuticals Provides Business Update and Announces Restructuring Plan
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Avanir Pharmaceuticals (NASDAQ: AVNR) today... |
March 29, 2007
05:30:00 AM |
#25: NewsBot: AVNR News AVANIR Pharmaceuticals Appoints New Chief Executive Officer
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today... |
March 14, 2007
05:30:00 AM |
#24: NewsBot: AVNR News AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today... |
February 28, 2007
04:30:00 AM |
#23: NewsBot: AVNR News AVANIR Pharmaceuticals Announces Conference Call to Provide Zenvia FDA Meeting Update
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today... |
February 27, 2007
05:00:00 AM |
#22: NewsBot: AVNR News AVANIR Pharmaceuticals Hires Martin J. Sturgeon as Vice President and Chief Accounting Officer
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today... |
February 12, 2007
01:10:00 PM |
#21: NewsBot: AVNR News AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Friday, February 9, 2007
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) will... |
January 16, 2007
01:10:00 PM |
#20: NewsBot: AVNR News AVANIR Pharmaceuticals Reports Fourth Quarter Fiscal 2006 Financial Results
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today reported... |
December 11, 2006
05:00:00 AM |
#19: NewsBot: AVNR News AVANIR Announces It Has Been Selected for Addition to the NASDAQ Biotechnology Index
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ: AVNR) announced today... |
November 16, 2006
01:15:00 PM |
#18: NewsBot: AVNR News AVANIR Pharmaceuticals Invites Investors to Listen to the Lazard Capital Markets 3rd Annual Life Sciences Conference Webcast
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) will be... |
November 15, 2006
01:43:00 PM |
#17: NewsBot: AVNR News AVANIR Announces Last Patient Enrolled in Neuropathic Pain Phase III Trial with Zenvia
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced today... |
November 14, 2006
01:05:00 PM |
#16: NewsBot: AVNR News AVANIR Announces Cost Reduction Initiatives and Provides Update on Zenvia for IEED
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced today... |
November 9, 2006
03:00:00 PM |
#15: NewsBot: AVNR News AVANIR Completes $15 Million Sale of Common Stock
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced that it... |
November 7, 2006
01:29:00 PM |
#14: NewsBot: AVNR News AVANIR Announces $15 Million Sale of Common Stock
SAN DIEGO--(BUSINESS WIRE)--Avanir Pharmaceuticals (NASDAQ:AVNR) announced that it... |
November 3, 2006
06:29:00 AM |
#13: NewsBot: AVNR News AVANIR Pharmaceuticals Invites Investors to Its Fourth Quarter Conference Call on Monday, December 11, 2006
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) will webcast its... |
November 2, 2006
02:15:00 PM |
#12: NewsBot: AVNR News AVANIR Receives FDA Approvable Letter for Zenvia for the Treatment of Involuntary Emotional Expression Disorder
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced that it... |
October 31, 2006
05:30:00 AM |
| 
| 
| 
| 
| 
| 
